EGR1 Knockout A-549 Cell Line
Cat.No.:
EDC07770
Species:
Human
Cell Name:
A-549
Gene:
EGR1
Gene ID:
1958
Size:
1×10⁶ cells
EGR1 Knockout Cell Line (A549) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07770 |
|---|---|
| Product Name | EGR1 Knockout A549 Cell Line |
| Cell Line | A-549 |
| Cellosaurus ID | CVCL_0023 |
| Cell Line Synonyms | A 549, A549, NCI-A549, A549/ATCC, A549 ATCC, A549ATCC, hA549 |
| Gene | EGR1 |
| NCBI Gene ID | |
| Gene Synonyms | AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268|ZIF268|ZNF225 |
| Summary |
The protein encoded by this gene belongs to the EGR family of C2H2-type zinc-finger proteins. It is a nuclear protein and functions as a transcriptional regulator. The products of target genes it activates are required for differentitation and mitogenesis. Studies suggest this is a cancer suppressor gene. [provided by RefSeq, Dec 2014]
|
| Associated Diseases | Non-Small Cell Lung Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5-1/4, 2days |
| Complete Culture Medium | F-12K + 10% FBS |
| Freezing Medium | 95% Complete culture medium + 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: A-549 | STR Info (Cell bank) Cell Line: A-549 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | Y | X | Y |
| CSF1PO | 10 | 12 | 10 | 12 |
| D2S1338 | 24 | 24 | ||
| D3S1358 | 16 | 16 | ||
| D5S818 | 11 | 11 | ||
| D7S820 | 8 | 11 | 8 | 11 |
| D8S1179 | 13 | 14 | 13 | 14 |
| D13S317 | 11 | 11 | ||
| D16S539 | 11 | 12 | 11 | 12 |
| D18S51 | 14 | 17 | 14 | 17 |
| D19S433 | 13 | 13 | ||
| D21S11 | 29 | 29 | ||
| FGA | 23 | 23 | ||
| Penta D | 9 | 9 | ||
| Penta E | 7 | 11 | 7 | 11 |
| TH01 | 8 | 9.3 | 8 | 9.3 |
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 14 | 14 | ||
| D6S1043 | 11 | 13 | ||
| D12S391 | 18 | 18 | ||
| D2S441 | 10 | 13 | 10 | 13 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying EGR1 function, EGR1 Knockout A-549 Cell Line or EGR1 overexpression A-549 Cell Line?
The choice depends on whether you are studying EGR1's role as an immediate-early gene transcription factor or its functions in lung cancer and cell proliferation. The Knockout line is the standard tool for asking whether EGR1 is required for these processes — EGR1 (early growth response 1, Zif268, Krox-24, NGFI-A) is a zinc finger transcription factor rapidly induced (within minutes) by growth factors, serum, stress, and neuronal activity; EGR1 binds GC-rich GCG(G/T)GGGCG response elements to drive expression of TGF-β, PTEN, p53, and other target genes. Overexpression is useful for studying EGR1 gain-of-function effects.
For lung cancer research, the EDITGENE EGR1 Knockout in A-549 is highly relevant — A-549 is an NSCLC cell line, and EGR1 has been characterized with context-dependent roles in lung cancer (both tumor suppressor and oncogenic in different contexts). Rescue with wild-type or DNA-binding-deficient EGR1 enables structure-function studies. The knockout is valuable for studying immediate-early gene biology, EGR1-mediated transcriptional responses, and emerging EGR1-related cancer biology.
What are the application scenarios for this model?
Primary applications:
• Immediate-early gene induction: serum/PMA stimulation followed by EGR1 protein and target gene (TGF-β1, PTEN) induction analysis in EGR1-null cells.
• Lung cancer biology: proliferation, migration, and apoptosis assays in NSCLC context.
• EGR1 target gene programs: RNA-seq analysis to characterize EGR1-dependent transcriptional programs.
• Zinc finger TF studies: in heterologous contexts, EGR1 GCG(G/T)GGGCG response element binding and target gene regulation.
EDITGENE recommends this lung cancer model for researchers investigating immediate-early gene biology and EGR1-mediated transcriptional responses.
Is this EGR1 Knockout A-549 Cell Line compatible with overexpression rescue experiments?
Yes. EGR1 rescue experiments require attention to zinc finger architecture:
• Construct design: use a codon-modified EGR1 sequence with a small C-terminal tag (FLAG, HA). EGR1 has N-terminal transactivation domain, three C2H2 zinc fingers (DNA binding), and C-terminal repressor-binding (NAB1/2) region — preserve all elements.
• DNA-binding-deficient rescue: zinc finger mutations abolish GCG(G/T)GGGCG element binding.
• Functional readout: rescue should restore EGR1-induced target gene expression (TGF-β1, PTEN).
A-549 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download